Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Professor's Model-Based Approach Helps Minimize Treatment Failure for HIV Patients

16.12.2011
Effective long-term treatment for patients living with HIV is complicated. Drug resistance is the leading cause of treatment failure and the development of new strains of the virus is common.

Ryan Zurakowski, assistant professor of electrical and computer engineering at the University of Delaware, has developed a treatment method to reduce the risk of future failures in patients who have already experienced failure with their HIV treatment protocol.

Patients are often treated with three-drug regimens that are highly effective at suppressing the virus in the long term, however, some patients become resistant to one or all three components of their regimen.

When this happens, patients must switch to a new regimen.

Zurakowski and his group are developing model-based approaches that minimize the risk of treatment failures for HIV patients who are switching therapies by considering both the contributions of viral load to the probability of failure.

Viral load measures the status of a patient’s infection level.

People with a high HIV viral load have a significantly higher chance of carrying a strain of HIV that will be resistant to subsequent medication regimens. This resistance can severely limit a patient’s treatment options.

“We are developing methods that would allow us to reduce the number of viral load measurements required without significantly decreasing the achieved reduction in risk,” said Zurakowski. “We are also developing ways to use the existing databases of HIV drug resistance mutations in order to choose the best drug combinations.”

Early results indicate that when a treatment fails, steps should be taken to reduce the viral load before switching to a new regimen. Starting treatment at a lower level of infection will significantly lower the chances of developing resistance.

For those who experience multiple failed therapies, Zurakowski also found that constructing a temporary "mix and match" regimen from previously failed combinations may minimize the risk of additional treatment failure.

If successful, Zurakowski’s research could help clinicians design and customize optimal treatment plans for transitioning patients whose antiviral regimen has failed to an alternate set of medications.

“The mathematical tools which are traditionally applied to aerospace, robotics and electrical design problems are equally applicable to problems of medical modeling and treatment planning,” Zurakowski explained.

Zurakowski’s research is documented in a paper entitled "Optimal Antiviral Switching to Minimize Resistance Risk in HIV Therapy." The paper was recently published in PLoS One, a peer-reviewed online science publication of the Public Library of Science. It has also been featured in the AIDS Beacon, an online publication provided by Light Knowledge Resources, an independent Internet publishing company based in Princeton, N.J.

About the researcher

Zurakowski joined UD in 2006. In addition to his faculty role in electrical and computer engineering, he is also affiliated with the Delaware Biotechnology Institute and holds appointments within the Department of Mathematical Sciences and the Biomedical Engineering program. His research centers on nonlinear control theory and applications, specifically in mathematical biology and medicine.

He received his doctorate in electrical and computer engineering from the University of California, Santa Barbara in 2004. Prior to joining UD, he was a postdoctoral researcher in the Department of Ecology and Evolutionary Biology at the University of California, Irvine.

Andrea Boyle | Newswise Science News
Further information:
http://www.udel.edu

More articles from Health and Medicine:

nachricht Periodic ventilation keeps more pollen out than tilted-open windows
29.03.2017 | Technische Universität München

nachricht Improving memory with magnets
28.03.2017 | McGill University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Periodic ventilation keeps more pollen out than tilted-open windows

29.03.2017 | Health and Medicine

Researchers discover dust plays prominent role in nutrients of mountain forest ecoystems

29.03.2017 | Earth Sciences

OLED production facility from a single source

29.03.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>